Determination of protein regions responsible for interactions of amelogenin with CD63 and LAMP1.
The enamel matrix protein amelogenin is secreted by ameloblasts into the extracellular space to guide the formation of highly ordered hydroxyapatite mineral crystallites, and, subsequently, is almost completely removed during mineral maturation. Amelogenin interacts with the transmembrane proteins CD63 and LAMP (lysosome-associated membrane protein) 1, which are involved in endocytosis. Exogenously added amelogenin has been observed to move rapidly into CD63/LAMP1-positive vesicles in cultured cells. In the present study, we demonstrate the protein region defined by amino acid residues 103-205 for CD63 interacts not only with amelogenin, but also with other enamel matrix proteins (ameloblastin and enamelin). A detailed characterization of binding regions in amelogenin, CD63 and LAMP1 reveals that the amelogenin region defined by residues PLSPILPELPLEAW is responsible for the interaction with CD63 through residues 165-205, with LAMP1 through residues 226-251, and with the related LAMP2 protein through residues 227-259. We predict that the amelogenin binding region is: (i) hydrophobic; (ii) largely disordered; and (iii) accessible to the external environment. In contrast, the binding region of CD63 is likely to be organized in a '7' shape within the mushroom-like structure of CD63 EC2 (extracellular domain 2). In vivo, the protein interactions between the secreted enamel matrix proteins with the membrane-bound proteins are likely to occur at the specialized secretory surfaces of ameloblast cells called Tomes' processes. Such protein-protein interactions may be required to establish short-term order of the forming matrix and/or to mediate feedback signals to the transcriptional machinery of ameloblasts and/or to remove matrix protein debris during enamel biomineralization.
Zou
YanMing
Y
University of Southern California School of Dentistry, Center for Craniofacial Molecular Biology, 2250 Alcazar Street, CSA Room 103, Los Angeles, CA 90033-1004, USA.
Wang
HongJun
H
Shapiro
Jason L
JL
Okamoto
Curtis T
CT
Brookes
Steven J
SJ
Lyngstadaas
S Petter
SP
Snead
Malcolm L
ML
Paine
Michael L
ML
D053523:Amelogenin / Q000737:chemistry / Q000378:metabolism*; D000595:Amino Acid Sequence; D000818:Animals; D015703:Antigens, CD / Q000737:chemistry / Q000378:metabolism*; D001483:Base Sequence; D001665:Binding Sites; D017931:DNA Primers; D051907:Lysosomal Membrane Proteins / Q000737:chemistry / Q000378:metabolism*; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010980:Platelet Membrane Glycoproteins / Q000737:chemistry / Q000378:metabolism*; D011487:Protein Conformation; D017386:Sequence Homology, Amino Acid; D060149:Tetraspanin 30; D020798:Two-Hybrid System Techniques; D052118:Lysosomal-Associated Membrane Protein 1
D053523:Amelogenin; D015703:Antigens, CD; D017931:DNA Primers; D051907:Lysosomal Membrane Proteins; D010980:Platelet Membrane Glycoproteins; D060149:Tetraspanin 30; C554587:Cd63 protein, mouse; C052255:Lamp1 protein, mouse; D052118:Lysosomal-Associated Membrane Protein 1
J Mol Biol. 2000 Jun 2;299(2):499-520
10860755
Calcif Tissue Int. 1994 Oct;55(4):302-10
7820782
J Mol Biol. 2004 Mar 26;337(3):635-45
15019783
J Bone Miner Res. 1996 Jul;11(7):892-8
8797108
J Histochem Cytochem. 1998 Aug;46(8):911-34
9671442
Science. 2005 Mar 4;307(5714):1450-4
15746422
Eur J Oral Sci. 1998 Oct;106(5):963-70
9786327
Cell Mol Life Sci. 2007 Jan;64(2):244-56
17187173
J Dent Res. 1998 Feb;77(2):377-86
9465170
J Dent Res. 1997 Nov;76(11):1720-9
9372788
Traffic. 2004 Sep;5(9):685-99
15296493
Proteins. 2005;61 Suppl 7:167-175
16187359
J Biol Chem. 2004 Sep 24;279(39):40263-6
15299015
Curr Opin Struct Biol. 2005 Feb;15(1):35-41
15718131
J Bone Miner Res. 1997 Feb;12(2):221-7
9041053
Cell Immunol. 1996 Jul 10;171(1):10-9
8660832
Trends Biochem Sci. 2003 Feb;28(2):106-12
12575999
Biopolymers. 1980 Mar;19(3):597-617
7357071
Cell Signal. 2003 Jun;15(6):559-64
12681443
J Biol Chem. 2001 Aug 24;276(34):31871-5
11406633
Gene. 1996 Dec 12;183(1-2):123-8
8996096
Nat Rev Mol Cell Biol. 2005 Mar;6(3):197-208
15738986
J Biol Chem. 1999 Apr 30;274(18):12692-701
10212251
Connect Tissue Res. 2003;44 Suppl 1:47-51
12952173
Proc Natl Acad Sci U S A. 1983 Dec;80(23):7254-8
6139813
Proteins. 2005 May 15;59(3):467-75
15768403
J Biol Chem. 2001 Oct 26;276(43):40055-64
11483611
J Cell Sci. 2001 Dec;114(Pt 23):4143-51
11739647
Bone. 2006 Feb;38(2):172-80
16214432
EMBO J. 2001 Jan 15;20(1-2):12-8
11226150
J Bone Miner Res. 2005 Jun;20(6):1032-40
15883644
Arch Oral Biol. 1971 Feb;16(2):147-56
4994434
Arch Oral Biol. 1961 Apr;3:217-20
13942053
Biopolymers. 1987 Oct;26(10):1809-13
3663856
Connect Tissue Res. 2003;44 Suppl 1:52-7
12952174
Mol Biol Cell. 2002 Mar;13(3):1071-82
11907283
J Dent Res. 2005 Dec;84(12):1127-32
16304441
J Struct Biol. 2005 Sep;151(3):239-49
16125972
Crit Rev Oral Biol Med. 1999;10(4):425-41
10634581
Mol Carcinog. 2001 Nov;32(3):139-53
11746826
J Dent Res. 1998 Mar;77(3):496-502
9496923
Nucleic Acids Res. 2003 Jul 1;31(13):3311-5
12824315
Biopolymers. 1994 Oct;34(10):1339-47
7948720
Biol Chem. 2002 Sep;383(9):1447-52
12437138
J Mol Biol. 2005 Apr 8;347(4):827-39
15769473
Nat Rev Immunol. 2005 Feb;5(2):136-48
15688041
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15560-5
14660791
J Dent Res. 2006 Sep;85(9):775-93
16931858
Mol Biol Cell. 2004 Jul;15(7):3132-45
15121881
J Biochem. 1993 Jan;113(1):55-60
8454575